Sorafenib Tosylate
Who holds supplier records for Sorafenib Tosylate? 16 organisations hold a current record for Sorafenib Tosylate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), China (5) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sorafenib Tosylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sorafenib-tosylate
Reading the evidence
- 16 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
10 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (16)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sorafenib Tosylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 34138, 29941 · latest filing Sept 2019
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 33727, 30180 · latest filing Mar 2019
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 36671 · latest filing Jan 2022
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChinaCEPActive DMF 32840 · latest filing Jul 2018
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 32642, 38033 · latest filing Feb 2023
- Granules India LimitedIndiaCEP Company GMP cert on recordActive DMF 37229 · latest filing Jun 2022
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 30235 · latest filing Jan 2016
- Shandong Loncom Pharmaceutical Co.,ltd.ChinaCEPActive DMF 44130 · latest filing May 2026
- TAPI NL BVNetherlandsCEPActive DMF 30234 · latest filing Feb 2016
- Natco PharmaIndia Company GMP cert on recordActive DMF 24578, 26693 · latest filing Dec 2012
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 28556 · latest filing Sept 2014
- Yabao Pharmaceutical Group Co., Ltd.ChinaActive DMF 29340 · latest filing Jun 2015
- BDR LIFESCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on record
- Shandong Anhong Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- IndiaCEP
- KINHOO PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (13)
Certificates of Suitability on the EDQM register for Sorafenib Tosylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED Sangareddy | IN | CEP 2023-185 - Rev 03 Sorafenib tosilate, Form-I, micronised and non-micronised | Nov 2026 | Inspected Aug 2026 Slovakia |
| TAPI NL B.V. Amsterdam | NL | CEP 2021-247 - Rev 03 Sorafenib tosilate | Jun 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2024-167 - Rev 00 Sorafenib tosilate | Feb 2026 | — |
| KINHOO PHARMACEUTICAL CO., LTD. Zhuhai | CN | CEP 2024-398 - Rev 00 Sorafenib tosilate | Feb 2026 | — |
| GRANULES INDIA LIMITED Hyderabad | IN | CEP 2022-386 - Rev 01 Sorafenib tosilate | Oct 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2021-324 - Rev 02 Sorafenib tosilate, Form-III | Jul 2025 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2022-056 - Rev 01 Sorafenib tosilate | Jun 2025 | — |
| BDR LIFESCIENCES PRIVATE LIMITED Luna Village | IN | CEP 2022-478 - Rev 01 Sorafenib tosilate | Jun 2025 | Inspected Jul 2025 Hungary |
| CHONGQING CARELIFE PHARMACEUTICAL CO., LTD. Chongqing | CN | CEP 2023-373 - Rev 00 Sorafenib tosilate | May 2025 | — |
| SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City | CN | CEP 2023-250 - Rev 02 Sorafenib tosilate, Micronised, polymorphic form I | May 2025 | Inspected Nov 2025 Greece |
| SHANDONG LONCOM PHARMACEUTICAL CO., LTD Dezhou | CN | CEP 2023-464 - Rev 00 Sorafenib tosilate | Apr 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2022-061 - Rev 01 Sorafenib tosilate | Dec 2023 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R0-CEP 2022-231 - Rev 00 Sorafenib tosilate | Jun 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Sorafenib Tosylate are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 27793 · filed Nov 2013
- Sichuan Xieli Pharmaceutical Co LtdChina · Inactive DMF 26460 · filed Sept 2012
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Sorafenib Tosylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200485).
Chemical identity
- IUPAC name
- 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
- Canonical SMILES
- CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
- InChIKey
- IVDHYUQIDRJSTI-UHFFFAOYSA-N
- Synonyms
- BAY 54-9085, BAY-54-9085, Nexavar, Sorafenib accord, Sorafenib tosilate, Sorafenib tosylate, NSC724772, BAY 43-9006 tosylate, CHEBI:50928, RefChem:57444, Sorafenib tosylate [USAN], Sorafenib (Tosylate)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Kinase Inhibitor
- Mechanism of action
- Protein Kinase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sorafenib Tosylate?
16 organisations hold an active US FDA Type II Drug Master File or a CEP for Sorafenib Tosylate: Alembic Pharmaceuticals Limited (India), MSN Laboratories Private Limited (India), APITORIA PHARMA PRIVATE LTD (India), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Cipla Limited (India), Granules India Limited (India), Hetero Labs Limited (India) and Shandong Loncom Pharmaceutical Co.,ltd. (China), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sorafenib Tosylate Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 34138, 29941), MSN Laboratories Private Limited (DMF 33727, 30180), APITORIA PHARMA PRIVATE LTD (DMF 36671), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 32840), Cipla Limited (DMF 32642, 38033), Granules India Limited (DMF 37229), Hetero Labs Limited (DMF 30235) and Shandong Loncom Pharmaceutical Co.,ltd. (DMF 44130) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sorafenib Tosylate records mean?
2 organisations have only inactive Type II DMFs for Sorafenib Tosylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Sorafenib Tosylate have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Sorafenib Tosylate on the EDQM register, including MSN LABORATORIES PRIVATE LIMITED Sangareddy (IN), TAPI NL B.V. Amsterdam (NL), CIPLA LIMITED Mumbai (IN), KINHOO PHARMACEUTICAL CO., LTD. Zhuhai (CN), GRANULES INDIA LIMITED Hyderabad (IN) and HETERO LABS LIMITED Hyderabad (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Sorafenib Tosylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sorafenib Tosylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.